Uniphar’s acquisition of Irish-headquartered pharmacy solutions business NaviCorp is to be investigated by the Competition and Consumer Protection Commission .
The deals were expected to deliver a return on capital employed to the group in line with Uniphar’s target rate of 12-15 per cent within three years.
IrishTimes So what if the final incarnation refuses to deal with the government on pharmaceutical pricing?
Portugal Últimas Notícias, Portugal Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Fonte: businessposthq - 🏆 8. / 71 Consulte Mais informação »
Fonte: IrishTimesBiz - 🏆 6. / 77 Consulte Mais informação »